<?xml version="1.0" encoding="UTF-8"?>
<p>Other important targets for cancer treatment, especially lymphomas, are histone deacetylases (HDACs). A series of coumarins (
 <xref ref-type="fig" rid="molecules-26-00501-f002">Figure 2</xref>, general structure 
 <bold>IV</bold>) exhibiting a hydroxamate structure similar to HDACi vorinostat (SAHA) has been published [
 <xref rid="B12-molecules-26-00501" ref-type="bibr">12</xref>]. The compounds show inhibitory activity in the nanomolar range, being higher in the case of propyl or methoxypropyl derivatives.
</p>
